These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 19165707

  • 1. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B, Aslami B, Backes H.
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [Abstract] [Full Text] [Related]

  • 2. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
    Khan A, Pawar G.
    W V Med J; 2005 Aug; 101(6):258-60. PubMed ID: 16625812
    [Abstract] [Full Text] [Related]

  • 3. Successful management of drooling with botulinum toxin A in neurologically disabled children.
    Ellies M, Rohrbach-Volland S, Arglebe C, Wilken B, Laskawi R, Hanefeld F.
    Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
    [Abstract] [Full Text] [Related]

  • 4. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH, Aburahma SK, Khader YS.
    Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S, Scheuer E, Buchman AS, Jacobson I, Ben-Zeev B.
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [Abstract] [Full Text] [Related]

  • 6. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
    Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D.
    Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [Abstract] [Full Text] [Related]

  • 9. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
    Nordgarden H, Østerhus I, Møystad A, Asten P, Johnsen UL, Storhaug K, Loven JØ.
    J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence.
    Schroeder AS, Kling T, Huss K, Borggraefe I, Koerte IK, Blaschek A, Jahn K, Heinen F, Berweck S.
    Neuropediatrics; 2012 Feb; 43(1):27-36. PubMed ID: 22430158
    [Abstract] [Full Text] [Related]

  • 11. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 12. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures.
    Erasmus CE, van Hulst K, Scheffer AR, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH.
    Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393
    [Abstract] [Full Text] [Related]

  • 13. Ultrasound-guided botulinum toxin injections for treatment of drooling.
    Breheret R, Bizon A, Jeufroy C, Laccourreye L.
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):224-9. PubMed ID: 21600865
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Does motor performance matter in botulinum toxin efficacy for drooling?
    Erasmus CE, Scheffer AR, van Hulst K, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH.
    Pediatr Neurol; 2011 Aug; 45(2):95-9. PubMed ID: 21763949
    [Abstract] [Full Text] [Related]

  • 17. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 18. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
    Sidebottom AJ, May JE, Madahar AK.
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
    [Abstract] [Full Text] [Related]

  • 19. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R, Diamond M, Elovic E, Millis SR.
    Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [Abstract] [Full Text] [Related]

  • 20. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ, Jongerius PH, Van Hulst K, Van Limbeek J, Rotteveel JJ.
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.